Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2CNS 1

Conditions

Glioblastoma 12Glioma 8Astrocytoma 4Oligodendroglioma 3Neoplasms 3Central Nervous System Neoplasms 3Brain Neoplasms 3Gliosarcoma 2Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Follicular 1Ependymoma 1

Interventions

Radiotherapy 6Temozolomide 5Flow Cytometry 5Cyclophosphamide 5Therapeutics 4Psychiatric Rehabilitation 4Melphalan 4Magnetic Resonance Spectroscopy 4Filgrastim 4sargramostim 3Specimen Handling 3Polymerase Chain Reaction 3Methylprednisolone 3liposomal amphotericin B 2Topotecan 2Thiotepa 2Rituximab 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Fentanyl 2Early Intervention, Educational 2Dexamethasone 2Caspofungin 2Carmustine 2Calcium Dobesilate 2Busulfan 2Aprepitant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × poly ICLC × CNS × Clear all
NCT02924038 2024-06-14

A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

University of California, San Francisco

Phase 1 Terminated
14 enrolled 10 charts
CNSLymphoid

Astrocytoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡